CVS Health Helping to Strengthen Communities Across Massachusetts

The company's community health investments are expanding access to housing, care and essential resources across the Commonwealth WOONSOCKET, R.I., July 22, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today highlighted its continued investments in improving the health of communities across Massachusetts, spanning affordable housing, collaborations with local nonprofit organizations and free health services.

PRNewsWire • 13 hours ago

2 Absurdly Cheap Healthcare Stocks to Buy Before July Ends

Healthcare is quietly becoming the value hunter's playground of 2026. While the mega cap tech trade keeps sucking up oxygen, two of the largest healthcare names in the S&P 500 are trading at forward multiples that look mispriced against their earnings power.

24/7 Wall Street • 14 hours ago

CVS is now filling prescriptions for dogs and cats. Here's what pet owners need to know

Next time you need to fill your pet's prescription, you might be able to pick up your own at the same time. Tuesday CVS Health announced plans to carry dog and cat medications alongside human ones in its pharmacies.

Fast Company • Jul 21, 2026

Pet medications now available at CVS Pharmacy®

Dog and cat owners can now fill common pet prescriptions at all CVS Pharmacy locations nationwide WOONSOCKET, R.I., July 21, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that common prescription medications for dogs and cats are now available at its approximately 9,000 CVS Pharmacy® locations nationwide.

PRNewsWire • Jul 21, 2026

CVS Health (CVS) Surpasses Market Returns: Some Facts Worth Knowing

The latest trading day saw CVS Health (CVS) settling at $110.6, representing a +2.78% change from its previous close.

Zacks Investment Research • Jul 21, 2026

Jim Cramer says this old-school investing concept still wins — even in the AI boom

CNBC's Jim Cramer urged investors to expand their portfolios beyond the market's hottest AI winners. "I'm not anti-tech.

CNBC • Jul 21, 2026

CVS Health Update: The C- Student Now Pulling Down A B+

CVS Health (CVS) is executing a significant turnaround, with new management driving operational improvements and a doubling of the share price since I last wrote in early 2025. CVS's fundamentals are solid: debt leverage is declining, cash flow is robust, and the Health Care Benefits segment's margin rebounded to 8.5% as of 1Q2026. Despite improved profitability and projected 10–15% annual EPS growth, CVS stock no longer appears to be in the bargain bin.

Seeking Alpha • Jul 20, 2026

CVS Pharmacy® celebrates opening of first pharmacy-focused location in Houston

Pharmacy-focused sites to open in select communities to help increase access to pharmacy care Openings are part of ongoing commitment to serve communities and meet consumers where they are  WOONSOCKET, R.I., July 17, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today unveiled its first pharmacy-focused CVS Pharmacy® in Houston.

PRNewsWire • Jul 17, 2026

Simpler prior authorizations, digital tools boost trust in insurers, Aetna president says

Less burdensome prior authorization procedures in which clinicians must have procedures and medicines preapproved by health plans and digital solutions for managing ​care have boosted trust in insurers, Aetna President Steve Nelson said on ‌Wednesday.

Reuters • Jul 15, 2026

FTC Says CVS Caremark Settlement Could Save Consumers Upto $13 Billion

The Federal Trade Commission (FTC) on Tuesday settled with CVS Health Corp. (NYSE:CVS) subsidiary Caremark, requiring the pharmacy benefit manager to overhaul key business practices aimed at lowering prescription drug costs, expanding transparency, and improving access to pharmacy services.

Benzinga • Jul 15, 2026